Microencapsulation peptide and protein drugs delivery system.

Colloids Surf B Biointerfaces

Key Laboratory of Biomechanics & Tissue Engineering under the State Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, PR China.

Published: March 2005

Many methods were used to devise peptide and protein drugs delivery system (DDS). Because of their relatively large size, they have low transdermal bioavailabilities. In systemic delivery of proteins, biodegradable material as parenteral depot formulation occupy an important place because of several aspects like protection of sensitive proteins from degradation, prolonged or modified release, pulsatile release patterns. The main objective in developing controlled release protein injectables is avoidance of regular invasive doses which in turn provide patient compliance, comfort as well as control over blood levels. This review article presents the outstanding contributions in field of microencapsulation as protein delivery systems and different approaches of protein delivery are described. Then discusses how these advances may be applied to resolve the challenges face the development of microcapsule for the controllable delivery of protein drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.colsurfb.2004.10.032DOI Listing

Publication Analysis

Top Keywords

protein drugs
12
peptide protein
8
drugs delivery
8
delivery system
8
protein delivery
8
protein
6
delivery
6
microencapsulation peptide
4
system methods
4
methods devise
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!